MediWound Ltd.
corporate_fare Company Profile
MediWound Ltd. (NASDAQ:MDWD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for MDWD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for MDWD spans 6-K, 424B5, 20-F.
Recent high-impact activity:
- MediWound Posts 65-Cent Quarterly Loss Per Share
- MediWound's $12.50 Bought Deal Grows to $17.25M as Wainwright Exercises Full Option
- MediWound Prices $15M Bought Deal at $12.50, a Premium to the $11.78 Close
- MediWound Launches Underwritten Share Offering With H.C. Wainwright; Terms Unpriced
- MediWound Secures $3.3M U.S. Funding for Room-Temp NexoBrid
Financial Snapshot
Short Interest & Short Volume
14.73 days to coverFINRA reported short interest of 1,790,576 shares in MDWD as of the October 30, 2026 settlement, a 2.3% increase from the prior period — about 14.7 days to cover at its recent average daily volume. On November 20, 2026, 58.6% of MDWD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for MDWD, detected from its recent SEC filings · based on capital-structure filings through 2026-11-05.
Bought Deal Terms Confirmed · Net Proceeds and Fees
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
MDWD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.